Catalyst Wire Dossier Catalyst Wire Dossier

ARRANON G

nelarabine · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARRANON G, covering 2017-11-01 to 2017-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg

See pricing